microbiome · foundational
Reference snapshot
This snapshot describes the state of the editorial record, not a diagnosis or a recommendation to intervene.
Claim ledger
Support not yet mapped. These editorial statements retain their original wording; related topic sources are available separately and have not been assigned as claim-specific support.
Signal
Gut-brain cross-talk models are robust at system level, while personalized nutrition studies now show both selective microbiome shifts and null primary metabolic outcomes depending on the intervention and endpoint.
Boundary
Moderate for diet-behavior relationships; low for person-specific prescriptions without prospective validation, repeat sampling, and clinical context.
Not established
Linked records do not establish a universal gut-brain axis protocol, diagnosis, or guaranteed outcome.
Mechanism map (working model)
A simplified causal map for orientation; it is not a diagnosis or a deterministic prediction.
Input or intervention
Diet pattern, fiber exposure, microbiome-targeted intervention, or stress context
Biological pathway
Microbial metabolites, immune signaling, gut barrier, and neural communication
Measurable signal
Symptoms, diet consistency, function, and validated outcomes rather than one stool snapshot
Boundary
Association does not establish a strain-level diagnosis or guaranteed probiotic response.
Research appraisal checklist
Evidence to prioritize
Replicated human studies with clear comparators, preregistered outcomes, usable follow-up, and transparent adverse-event reporting.
Outcome anchor
Anchor the claim to a meaningful functional or clinical outcome rather than a single dashboard metric or biomarker.
Main uncertainty
The main uncertainty is ecological and protocol specificity: strain or donor identity, engraftment, pathogen controls, host context, and persistence over time.
What would change the conclusion
Upgrade confidence only when independent studies reproduce the result and make harms, adherence, and durability visible.
Minimum diligence questions
- Are the intervention, dose or exposure, comparator, population, and measurement conditions clearly defined?
- Do the outcomes matter outside the experiment, and are missing data, adverse events, and conflicts visible?
- Can the result be reproduced independently, and does it justify the level of risk being discussed?
Application and translation pathway
Current application boundary
Gut-Brain Axis is currently best understood as a foundational microbiome domain; practical use should stay within the evidence and safety boundary described in this dossier.
Research and applied uses
- Measurement and hypothesis testing in microbiome
- Protocol design with defined outcomes and context
- Low-risk applied experimentation with reversible changes
A staged map for separating an interesting mechanism from a reproducible, useful, and responsibly deployable application.
Question
Define the population, intervention, comparator, and outcome before interpreting a signal.
Signal
Check measurement validity, adherence, confounding, and whether the result repeats.
Function
Ask whether the change improves meaningful daily function or clinical outcomes.
Boundary
Preserve normal functioning and stop when symptoms or risk increase.
Research and clinical readout
Research status
Gut-brain cross-talk models are robust at system level, while personalized nutrition studies now show both selective microbiome shifts and null primary metabolic outcomes depending on the intervention and endpoint.
Signal confidence
Grade B (Moderate for diet-behavior relationships; low for person-specific prescriptions without prospective validation, repeat sampling, and clinical context.)
Key question
Which microbiome-linked effects persist after accounting for diet quality, adherence, stress, medications, and baseline metabolic status?
Clinical perspective
Use only when aligned with validated diagnostics and dietary/behavioral context.
Clinical uncertainty
Commercial interpretation of stool-level metrics and causal claims.
Community patterns
Practical gains often come from broad consistency habits rather than single strain claims.
Common community failure mode
Treating test snapshots as fixed truth.
Where this is heading
Mechanistic integration with metabolomics and sleep/stress metrics is growing.
What to track next
Bidirectional signaling between gut ecology, neurobiology, mood, and systemic inflammation.
Protocol and safety scaffold
Risk gate: Start with low-risk foundations and preserve normal functioning while testing one variable.
Baseline first
- Define one meaningful outcome and a comparison window before changing the protocol.
- Record relevant symptoms, sleep, workload, medications, and confounders at baseline.
Implementation pattern
- Change one variable at a time and use the smallest meaningful intervention.
- Predefine review, washout, and escalation criteria before looking at results.
Monitor
- Track the target outcome alongside symptoms, function, and adherence.
- Check data quality and context before treating a change as a signal.
Pause or stop rules
- Pause for new or worsening symptoms, reduced normal function, or a meaningful safety concern.
- Pause signal: Commercial probiotic shopping as a standalone precision strategy.
Clinician gate
Use clinician review for persistent symptoms, medication changes, abnormal results, pregnancy, or a diagnosed medical condition.
Glossary connections
Controversies to monitor
Controversies
- Overstating probiotic and prebiotic effects.
- Confounding by major lifestyle shifts.
Core reference classes
Research classes
- Gut-brain mechanistic literature
- Clinical microbiome interpretation guidance
Evidence timeline
Linked records are ordered by publication year. A newer record is not automatically stronger; design, population, and endpoint still determine weight.
The Oral Microbiome as a Regulatory Hub for Systemic Health
Journal of Oral Microbiology / PubMed - Systematic review
A 2026 systematic review synthesizes mechanistic and clinical links between oral dysbiosis, periodontal inflammation, and systemic conditions while identifying major gaps in causal and interventional evidence.
View source recordThe Oral-Gut Axis in Periodontal Disease
Journal of Oral Microbiology / PubMed - Systematic review of human evidence
A 2026 review assesses human evidence for oral-gut pathways in periodontal disease and calls for prospective, comparative, and standardized research before strong clinical claims are made.
View source recordGut Microbial Dysbiosis and Psychiatric Disorders
Frontiers in Neuroscience / PubMed Central - Systematic review
A 2026 systematic review reports candidate microbiome signatures across psychiatric conditions while emphasizing the need for standardized methods, longitudinal work, and validation before diagnostic use.
View source recordProbiotic and Postbiotic Strains in Adults With Mild Anxiety
Nutrients / PubMed - Randomized double-blind placebo-controlled trial
A 2026 trial evaluated live probiotic and heat-treated postbiotic preparations in healthy adults with self-reported anxiety and mild stress, measuring mood, perceived stress, sleep, cortisol, gastrointestinal symptoms, and microbiome changes.
View source recordWhole-Food Plant Diversity and the Gut Microbiome
British Journal of Nutrition / PubMed - Randomized controlled trial
A six-week randomized trial in 399 adults tested a diverse whole-food plant blend and reported changes in more microbiome species than control; interpretation still depends on the study's defined ranking, duration, adherence, and clinical endpoints.
View source recordFecal Microbiota Transplantation-Based Treatment for Chronic Insomnia
Journal of Internal Medicine / PubMed - Multicenter randomized double-blind placebo-controlled clinical trial
A multicenter randomized trial tested a fecal microbiota transplantation-based protocol with antibiotic pretreatment and donor microbiota capsules in adults with chronic insomnia; polysomnography, patient-reported sleep outcomes, safety, and exploratory microbiome measures require separate interpretation.
View source recordOnline-Guided Physical Activity, Cognition, Brain Connectivity, and the Gut Microbiome
GeroScience / PubMed - Randomized controlled trial
A randomized trial in healthy older adults evaluated an online-guided physical-activity intervention alongside cognition, resting-state brain connectivity, and gut-microbiome outcomes; the multimodal design is informative but does not isolate a single mechanism or establish a universal digital exercise protocol.
View source recordEfficacy and Safety of Postbiotics in Irritable Bowel Syndrome
Journal of Gastroenterology and Hepatology / PubMed - Systematic review and meta-analysis of randomized trials
A meta-analysis of randomized trials in adults with irritable bowel syndrome found possible symptom and abdominal-pain benefits with low certainty and substantial need for standardized, longer studies.
View source recordGut Microbiota and Personalized Fiber Response in Prediabetes
Nature Medicine / PubMed - Randomized open-label clinical trial
An open-label randomized trial assigned 802 people with prediabetes to usual care or a dietary-fiber intervention for six months; the primary HbA1c outcome did not differ significantly, while post-hoc clusters suggested heterogeneity that requires prospective validation.
View source recordEffect of Different Dietary Patterns on Patients with Depressive Disorders
Nutrients / PubMed - Systematic review and meta-analysis of randomized controlled trials
A review of randomized diet trials in depressive disorders found a limited and heterogeneous evidence base, illustrating why nutrition should be framed as individualized adjunctive support rather than a universal replacement for psychiatric care.
View source recordPrebiotic and Probiotic Interventions in the Gut Feelings Trial
Nutritional Neuroscience / PubMed - 2×2 factorial randomized controlled trial
A factorial randomized trial in 118 adults with low mood and potential for dietary improvement tested a prebiotic-rich diet, probiotic supplementation, and their combination while measuring cognitive outcomes.
View source recordPersonalized Nutrition Program for Cardiometabolic Health
Nature Medicine / PubMed - Randomized controlled trial
An 18-week randomized trial in 347 adults compared a program using food characteristics, postprandial responses, microbiome data, and health history with general dietary advice; triglycerides and several secondary outcomes improved, while LDL cholesterol did not differ significantly.
View source recordTopic assessment
These questions test evidence interpretation and safety boundaries, not personal medical decisions.
1. What is the most defensible first question when evaluating Gut-Brain Axis?
Show answer and explanation
What outcome, evidence, and risk boundary are defined?
A clear outcome, evidence design, and risk boundary keep an encyclopedia claim from becoming an unsafe recommendation.
2. What would make a claim about Gut-Brain Axis more trustworthy?
Show answer and explanation
Replication with appropriate controls, context, and meaningful outcomes
Reproducibility and patient-important outcomes matter more than novelty, complexity, or an isolated signal.
Editorial update history
This log records what changed in the encyclopedia record and why the update matters for interpretation.
A-Z topic scaffolding, safety framing, learning paths, and linked evidence architecture established for the living encyclopedia.
Added current records spanning real-world digital cohorts, multi-omics, serum proteomics, sweat biosensing, peptides, aging clocks, kinase signaling, endocrine research, personalized nutrition, microbiome response, neurotechnology, and caloric restriction.
Related record update: Personalized Nutrition Program for Cardiometabolic Health; Gut Microbiota and Personalized Fiber Response in Prediabetes; Whole-Food Plant Diversity and the Gut Microbiome
Added recent human records on microbiome-based insomnia treatment, online-guided activity and cognition, technology-assisted behavior change, and next-generation epigenetic aging clocks, with explicit translation and conflict boundaries.
Related record update: Fecal Microbiota Transplantation-Based Treatment for Chronic Insomnia; Online-Guided Physical Activity, Cognition, Brain Connectivity, and the Gut Microbiome
Added dossiers for ketamine and esketamine, sleep apnea, cuffless blood pressure, extracellular vesicles, exercise mimetics, postbiotics, nutritional psychiatry, and plasma-exchange rejuvenation claims, with clinical boundaries, community-risk framing, and current research links.
Related record update: Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome; Effect of Different Dietary Patterns on Patients with Depressive Disorders
Added female fertility and ovarian-reserve interpretation, menstrual-cycle and energy-availability boundaries, oral microbiome and periodontal-health coverage, and skin photoaging and photoprotection evidence with device-specific and clinical safeguards.
Related record update: The Oral Microbiome as a Regulatory Hub for Systemic Health; The Oral-Gut Axis in Periodontal Disease
Linked evidence records
The Oral Microbiome as a Regulatory Hub for Systemic Health
Journal of Oral Microbiology / PubMed • Systematic review • Published: 2026 • Checked: Aug 17, 2026
A 2026 systematic review synthesizes mechanistic and clinical links between oral dysbiosis, periodontal inflammation, and systemic conditions while identifying major gaps in causal and interventional evidence.
How to interpret this record
What it supports
Oral dysbiosis and periodontal inflammation have plausible and observed associations with several systemic conditions through inflammatory, microbial, and immune pathways.
Major limitations
Much of the systems-health literature is mechanistic, observational, or heterogeneous, so causal direction and intervention benefit remain uncertain.
What it does not establish
A microbiome profile, probiotic, rinse, or oral supplement is not established as a stand-alone prevention or treatment for systemic disease.
The Oral-Gut Axis in Periodontal Disease
Journal of Oral Microbiology / PubMed • Systematic review of human evidence • Published: 2026 • Checked: Aug 17, 2026
A 2026 review assesses human evidence for oral-gut pathways in periodontal disease and calls for prospective, comparative, and standardized research before strong clinical claims are made.
How to interpret this record
What it supports
Human evidence supports studying oral-gut pathways in periodontal disease, including dysbiosis, inflammation, and possible effects on downstream physiology.
Major limitations
The field needs prospective comparative studies, standardized sampling, and clinically meaningful intervention outcomes.
What it does not establish
An oral-gut association does not validate detoxes, oil pulling, DIY antimicrobials, or claims that oral testing can diagnose distant disease.
Gut Microbial Dysbiosis and Psychiatric Disorders
Frontiers in Neuroscience / PubMed Central • Systematic review • Published: 2026 • Checked: Aug 17, 2026
A 2026 systematic review reports candidate microbiome signatures across psychiatric conditions while emphasizing the need for standardized methods, longitudinal work, and validation before diagnostic use.
How to interpret this record
What it supports
Microbiome patterns are being studied as candidate associations with psychiatric conditions and gut-brain signaling.
Major limitations
Observational designs, diet, medication, geography, and assay differences can confound microbial signatures.
What it does not establish
A microbiome profile is not a psychiatric diagnosis or proof that a probiotic will correct it.
Probiotic and Postbiotic Strains in Adults With Mild Anxiety
Nutrients / PubMed • Randomized double-blind placebo-controlled trial • Published: 2026 • Checked: Aug 17, 2026
A 2026 trial evaluated live probiotic and heat-treated postbiotic preparations in healthy adults with self-reported anxiety and mild stress, measuring mood, perceived stress, sleep, cortisol, gastrointestinal symptoms, and microbiome changes.
How to interpret this record
What it supports
The trial directly tests defined live and inactivated microbial preparations against placebo across mood, stress, sleep, cortisol, gastrointestinal, and microbiome outcomes.
Major limitations
Effects are strain- and population-specific, and microbiome, symptom, and biomarker outcomes may not move together; independent replication remains important.
What it does not establish
A probiotic or postbiotic blend is not a general anxiety treatment, diagnostic, or guaranteed gut-brain intervention.
Prebiotic and Probiotic Interventions in the Gut Feelings Trial
Nutritional Neuroscience / PubMed • 2×2 factorial randomized controlled trial • Published: 2024 • Checked: Aug 17, 2026
A factorial randomized trial in 118 adults with low mood and potential for dietary improvement tested a prebiotic-rich diet, probiotic supplementation, and their combination while measuring cognitive outcomes.
How to interpret this record
What it supports
The factorial design can separate some prebiotic, probiotic, and combined intervention effects on cognition in adults with low mood and diet-improvement potential.
Major limitations
Dietary changes, baseline mood, adherence, and strain-specific effects complicate attribution and generalization.
What it does not establish
One factorial trial does not validate a universal microbiome diet, probiotic stack, or cognitive-enhancement protocol.
Personalized Nutrition Program for Cardiometabolic Health
Nature Medicine / PubMed • Randomized controlled trial • Published: 2024 • Checked: Aug 17, 2026
An 18-week randomized trial in 347 adults compared a program using food characteristics, postprandial responses, microbiome data, and health history with general dietary advice; triglycerides and several secondary outcomes improved, while LDL cholesterol did not differ significantly.
How to interpret this record
What it supports
An 18-week randomized trial provides human evidence that a multi-input personalized nutrition program can change some cardiometabolic outcomes relative to general dietary advice.
Major limitations
LDL cholesterol did not differ significantly, adherence influenced secondary outcomes, and extensive industry relationships are relevant to interpretation.
What it does not establish
The study does not validate every commercial microbiome or postprandial-response algorithm, nor a universal individualized diet for healthy people.
Gut Microbiota and Personalized Fiber Response in Prediabetes
Nature Medicine / PubMed • Randomized open-label clinical trial • Published: 2025 • Checked: Aug 17, 2026
An open-label randomized trial assigned 802 people with prediabetes to usual care or a dietary-fiber intervention for six months; the primary HbA1c outcome did not differ significantly, while post-hoc clusters suggested heterogeneity that requires prospective validation.
How to interpret this record
What it supports
A large randomized trial can test whether a fiber intervention changes glycemic outcomes while measuring microbiome heterogeneity.
Major limitations
The primary and secondary outcomes did not show significant between-group differences; the suggested responder clusters were post-hoc and need prospective validation.
What it does not establish
A microbiome cluster from this study is not a diagnostic label or proof that a personalized fiber protocol will prevent diabetes.
Whole-Food Plant Diversity and the Gut Microbiome
British Journal of Nutrition / PubMed • Randomized controlled trial • Published: 2026 • Checked: Aug 17, 2026
A six-week randomized trial in 399 adults tested a diverse whole-food plant blend and reported changes in more microbiome species than control; interpretation still depends on the study's defined ranking, duration, adherence, and clinical endpoints.
How to interpret this record
What it supports
A recent randomized diet trial provides evidence that a diverse whole-food intervention can shift selected microbiome species over six weeks.
Major limitations
Species-ranking endpoints, short follow-up, dietary adherence, and the relationship between microbiome shifts and clinical outcomes all limit translation.
What it does not establish
More species changes do not automatically mean better health, and the study does not establish a supplement stack or a universal microbiome target.
Fecal Microbiota Transplantation-Based Treatment for Chronic Insomnia
Journal of Internal Medicine / PubMed • Multicenter randomized double-blind placebo-controlled clinical trial • Published: 2026 • Checked: Aug 17, 2026
A multicenter randomized trial tested a fecal microbiota transplantation-based protocol with antibiotic pretreatment and donor microbiota capsules in adults with chronic insomnia; polysomnography, patient-reported sleep outcomes, safety, and exploratory microbiome measures require separate interpretation.
How to interpret this record
What it supports
A multicenter randomized trial provides clinical-context evidence for studying a defined microbiome-transplant protocol in chronic insomnia.
Major limitations
Antibiotic pretreatment, donor material, capsule protocol, polysomnography endpoint, participant selection, safety follow-up, and exploratory microbiome analysis limit generalization.
What it does not establish
The study does not establish home FMT, donor products, or microbiome manipulation as a general sleep or mental-health protocol.
Online-Guided Physical Activity, Cognition, Brain Connectivity, and the Gut Microbiome
GeroScience / PubMed • Randomized controlled trial • Published: 2026 • Checked: Aug 17, 2026
A randomized trial in healthy older adults evaluated an online-guided physical-activity intervention alongside cognition, resting-state brain connectivity, and gut-microbiome outcomes; the multimodal design is informative but does not isolate a single mechanism or establish a universal digital exercise protocol.
How to interpret this record
What it supports
A randomized trial can test whether structured online-guided activity is associated with changes in cognition and multimodal brain or microbiome measures in a defined older population.
Major limitations
The intervention is multimodal, outcomes may be population-specific, and parallel changes cannot identify a single causal mechanism or guarantee transfer to other groups.
What it does not establish
A multimodal activity trial does not prove that a consumer app, microbiome shift, or connectivity measure independently improves cognition.
Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome
Journal of Gastroenterology and Hepatology / PubMed • Systematic review and meta-analysis of randomized trials • Published: 2026 • Checked: Aug 17, 2026
A meta-analysis of randomized trials in adults with irritable bowel syndrome found possible symptom and abdominal-pain benefits with low certainty and substantial need for standardized, longer studies.
How to interpret this record
What it supports
A small randomized-trial synthesis supports possible symptom and pain benefits for defined postbiotic formulations in adults with irritable bowel syndrome.
Major limitations
Certainty is low, formulations differ, heterogeneity is meaningful, and the results do not generalize automatically to other symptoms or products.
What it does not establish
The review does not establish universal microbiome repair, treatment of unexplained gastrointestinal disease, or interchangeability with probiotics.
Effect of Different Dietary Patterns on Patients with Depressive Disorders
Nutrients / PubMed • Systematic review and meta-analysis of randomized controlled trials • Published: 2025 • Checked: Aug 17, 2026
A review of randomized diet trials in depressive disorders found a limited and heterogeneous evidence base, illustrating why nutrition should be framed as individualized adjunctive support rather than a universal replacement for psychiatric care.
How to interpret this record
What it supports
The review evaluates randomized dietary-pattern trials in depressive disorders and clarifies the current evidence base and its uncertainty.
Major limitations
Only a small number of trials and dietary patterns were available, with short duration and variation in control, adherence, and psychiatric care.
What it does not establish
The review does not establish a universal antidepressant diet or justify stopping medication or mental-health treatment.